​

Medline (MDLN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MDLN Stock Forecast

Medline (MDLN) stock forecast, based on 17 Wall Street analysts, predicts a 12-month average price target of $44.11, with a high of $55.00 and a low of $37.00. This represents a 21.65% increase from the last price of $36.26.

MDLN Stock Rating

Medline stock's rating consensus is Buy, based on 17 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (88.24%), 2 Hold (11.76%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 17 0 2 15 Strong Sell Sell Hold Buy Strong Buy

MDLN Price Target Upside V Benchmarks

TypeNameUpside
StockMedline21.65%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks11.77%

Price Target Trends

1M3M12M
# Anlaysts2938
Avg Price Target$43.00$44.11$47.42
Last Closing Price$36.26$36.26$36.26
Upside/Downside18.59%21.65%30.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 267164--27
Sep, 267164--27
Aug, 266164--26
Jul, 267174--28
Jun, 267174--28
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 09, 2026Barclays$43.00$35.7420.31%18.59%
Sep 25, 2026Kevin CaliendoUBS$43.00$34.8123.53%18.59%
Aug 27, 2026David LarsenBTIG$55.00$34.5859.05%51.68%
Aug 06, 2026Eric ColdwellRobert W. Baird$42.00$35.3018.98%15.83%
Aug 06, 2026Evercore ISI$39.00$35.719.21%7.56%
Aug 06, 2026Stifel Nicolaus$45.00$35.5426.62%24.10%
Aug 06, 2026Sean DodgeBMO Capital$47.00$36.6728.17%29.62%
Aug 06, 2026RBC Capital$46.00$36.6725.44%26.86%
Aug 06, 2026Deutsche Bank$37.00$36.670.90%2.04%
Jun 03, 2026Eric ColdwellRobert W. Baird$45.00$33.1935.58%24.10%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 25, 2026UBSBuyBuyhold
Sep 23, 2026William BlairOutperformOutperformhold
Aug 27, 2026BTIGBuyBuyhold
Aug 06, 2026BMO CapitalOutperformOutperformhold
Jun 04, 2026William BlairOutperformOutperformhold
Jun 01, 2026BarclaysOverweightOverweighthold
May 13, 2026Tigress FinancialBuyBuyhold
May 07, 2026CitigroupBuyBuyhold
Feb 25, 2026Evercore ISIOutperformOutperformhold
Feb 05, 2026Tigress FinancialBuyinitialise

Financial Forecast

EPS Forecast

Dec 25 Dec 26
Dec 25Dec 26
Reported--
Avg Forecast$1.21$1.48
High Forecast$1.31$1.52
Low Forecast$1.18$1.42
Surprise %--

Revenue Forecast

$28B $28B $29B $30B $30B $31B Dec 25 Dec 26
Dec 25Dec 26
Reported--
Avg Forecast$28.14B$30.52B
High Forecast$28.18B$30.98B
Low Forecast$27.98B$30.15B
Surprise %--

Net Income Forecast

$900M $960M $1B $1B $1B $1B Dec 25 Dec 26
Dec 25Dec 26
Reported--
Avg Forecast$950.74M$1.16B
High Forecast$1.03B$1.20B
Low Forecast$928.80M$1.12B
Surprise %--

MDLN Forecast FAQ

Is Medline stock a buy?

Medline stock has a consensus rating of Buy, based on 17 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Medline is a favorable investment for most analysts.

What is Medline's price target?

Medline's price target, set by 17 Wall Street analysts, averages $44.11 over the next 12 months. The price target range spans from $37 at the low end to $55 at the high end, suggesting a potential 21.65% change from the previous closing price of $36.26.

How does Medline stock forecast compare to its benchmarks?

Medline's stock forecast shows a 21.65% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (11.77%).

What is the breakdown of analyst ratings for Medline over the past three months?

  • October 2026: 25.93% Strong Buy, 59.26% Buy, 14.81% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 25.93% Strong Buy, 59.26% Buy, 14.81% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 23.08% Strong Buy, 61.54% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.

What is Medline’s EPS forecast?

Medline's average annual EPS forecast for its fiscal year ending in December 2025 is $1.21, marking a 0% decrease from the reported - in 2024. Estimates for the following years are.

What is Medline’s revenue forecast?

Medline's average annual revenue forecast for its fiscal year ending in December 2025 is $28.14B, reflecting a 0% decrease from the reported - in 2024. The forecast for.

What is Medline’s net income forecast?

Medline's net income forecast for the fiscal year ending in December 2025 stands at $950.74M, representing a 0% decrease from the reported - in 2024. Projections indicate .